SEC Form 4 · accession 0000914190-15-000147

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Mar 31, 2015

Accepted (ET)

Apr 2, 2015 · 4:32 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000842023

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 31, 2015	M	1,666	—	A	1,666	D
Common Stock	Mar 31, 2015	F	566	$100.29	D	1,100	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F2	—	Mar 31, 2015	M	1,666	D	—	—	Common Stock	1,666	3,334	D
Stock Option (Right to Buy)^F3	$86.25	holding	—	—	—	—	Apr 1, 2021	Common Stock	25,000	25,000	D
Stock Option (Right to Buy)^F4	$86.25	holding	—	—	—	—	Apr 1, 2021	Common Stock	10,000	10,000	D
Stock Option (Right to Buy)^F5	$94.35	holding	—	—	—	—	Aug 12, 2021	Common Stock	35,000	35,000	D

F1Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F2On April 1, 2014, the reporting person was granted 5,000 restricted stock units, vesting in three equal annual installments beginning on March 31, 2015.
F3Vests 6,250 shares on each of April 1, 2015, April 1, 2016, April 1, 2017 and April 1, 2018.
F4This performance based stock option award will vest if, and only if, certain performance goals are achieved, which performance goals will be established by the Executive Compensation Committee within 60 days of the grant date.
F5Vests 8,750 shares on each of August 12, 2015, August 12, 2016, August 12, 2017 and August 12, 2018.